Inj PAM 2gm for wht
Reading File
Searching the Web
pralidoxime PAM 2g injection organophosphate poisoning indication mechanism
Finding Sources
Reading File
Reading File
Injection Pralidoxime (2-PAM) 2g - Indication & Clinical Use
Injection Pralidoxime (PAM) 2g is used for Organophosphate (OP) Poisoning.
What is it?
Pralidoxime (2-PAM, P-2-AM) is an oxime - a cholinesterase reactivator used as an antidote in organophosphate poisoning. It is always given alongside atropine, not alone.
Mechanism of Action
Organophosphates (OP compounds - pesticides like malathion, parathion; nerve agents like sarin) irreversibly inhibit acetylcholinesterase (AChE), causing accumulation of acetylcholine at all synapses.
Pralidoxime works by:
- Binding to the OP-cholinesterase complex
- Causing a conformational change that displaces the phosphate group from the enzyme
- Regenerating (reactivating) acetylcholinesterase so it can resume normal function
Key point: PAM must be given before "aging" occurs - once the OP-AChE bond ages (becomes fully irreversible, typically within 24-48 hours), PAM is ineffective. Earlier = better.
Indications
- Acute organophosphate poisoning (primary use) - pesticide exposure (farmers, agricultural workers), suicidal ingestion, industrial accidents, nerve agent exposure
- Anticholinesterase drug overdose - e.g., excess neostigmine/pyridostigmine used in myasthenia gravis
Clinical Features PAM Targets (Nicotinic effects)
Atropine covers muscarinic symptoms (SLUDGE/DUMBELS). PAM is critical because it also reverses nicotinic effects that atropine cannot:
- Muscle weakness and paralysis
- Respiratory muscle paralysis (the main cause of death)
- Fasciculations
Dosing (Adult)
| Route | Dose | Administration |
|---|---|---|
| IV (preferred) | 2g (30 mg/kg) | Slow IV infusion over 15-30 min in 100 mL NS |
| Repeat | 1-2g after 1 hour if needed | Then every 6-12 hours for 24-48 hours |
| Continuous infusion | 500 mg/hr | For severe/ongoing poisoning |
Pediatric: 20-50 mg/kg (max 2g per dose)
Key Points
- Always give atropine first (or simultaneously) - PAM alone is not sufficient
- PAM does not cross the blood-brain barrier (due to its quaternary ammonium group), so it does not reverse CNS effects of OP poisoning
- Give as slow IV infusion - rapid IV push can cause tachycardia, hypertension, laryngospasm
- Most effective if given within 4-6 hours of exposure
Mnemonic
PAM = Phosphate Antidote for Muscle (reactivates AChE at the neuromuscular junction)
Sources: Rosen's Emergency Medicine; Tintinalli's Emergency Medicine; Lippincott Pharmacology; Katzung's Basic & Clinical Pharmacology
acetylcholinesterase vs cholinesterase in poisoning which test is preferred
Finding Sources
Searching the Web
RBC acetylcholinesterase vs plasma cholinesterase organophosphate poisoning which test preferred
Finding Sources
Finding Sources
Searching PubMed
RBC acetylcholinesterase plasma cholinesterase organophosphate poisoning diagnosis
Reading File
Reading File
Reading File
Excellent - the textbook has the complete, authoritative answer. Here is the full breakdown:
RBC Acetylcholinesterase vs Plasma (Pseudo)cholinesterase in OP Poisoning
The Two Tests
| Feature | RBC Acetylcholinesterase (True AChE) | Plasma Pseudocholinesterase (BuChE) |
|---|---|---|
| Other names | True cholinesterase, erythrocyte AChE | Plasma cholinesterase, butyrylcholinesterase, false cholinesterase |
| Location | RBCs, nerve tissue, neuromuscular junctions | Plasma / liver |
| Substrate specificity | Highly specific - primarily ACh | Nonspecific - hydrolyzes ACh + many other esters |
| Sensitivity | Less sensitive (falls later) | More sensitive (falls earlier) |
| Specificity | More specific for OP poisoning | Less specific |
Which is Preferred?
RBC acetylcholinesterase (erythrocyte AChE) is the PREFERRED and more specific test.
The key reason, directly from Henry's Clinical Diagnosis (a laboratory medicine textbook):
"Only inhibition of AChE is considered specific for organophosphate poisoning because a number of conditions may produce a low plasma pseudocholinesterase level. Thus, the latter measurement is more sensitive but less specific than the red blood cell cholinesterase level."
- RBC AChE directly mirrors what is happening at nerve synapses and the neuromuscular junction - it is a true surrogate for neural AChE inhibition
- Plasma pseudocholinesterase falls in many other conditions (liver disease, malnutrition, pregnancy, genetic deficiency, some medications), making it non-specific
Why Plasma Cholinesterase is Still Used
Despite being less specific, plasma pseudocholinesterase is still commonly ordered because:
- It is technically easier and faster to measure in most labs
- It falls earlier (more sensitive) - can detect lower-level exposures sooner
- It regenerates faster after poisoning (2 weeks vs 3 months for RBC AChE), making it useful for monitoring recovery
Interpreting the Levels
| Level (% of normal) | Interpretation |
|---|---|
| 70-100% | Normal |
| 50-70% | Mild inhibition / exposure |
| 30-50% | Moderate - indicates significant exposure |
| <30% | Severe inhibition - toxic manifestations expected |
| <20% | Symptomatic poisoning typically present |
Note: Symptoms may not appear until levels fall to 20% or less of normal. Because baseline pre-exposure values are rarely known, sequential (serial) measurements are the most useful approach - a falling trend confirms ongoing poisoning.
Practical Summary
- Preferred/Specific test: RBC acetylcholinesterase
- More sensitive/Earlier marker: Plasma pseudocholinesterase
- Best practice: Measure both on presentation, then follow serially
- Recovery monitoring: Plasma cholinesterase normalizes in ~2 weeks; RBC AChE takes up to 3 months (as RBCs turn over)
Source: Henry's Clinical Diagnosis and Management by Laboratory Methods
This is a shared conversation. Sign in to Orris to start your own chat.